|Titre :||Illicit drug use among rave attendees in a nationally representative sample of US high school seniors (2015)|
|Auteurs :||J. J. PALAMAR ; M. GRIFFIN-TOMAS ; D. C. OMPAD|
|Type de document :||Article : Périodique|
|Dans :||Drug and Alcohol Dependence (Vol.152, July 2015)|
|Article en page(s) :||24-31|
|Discipline :||EPI (Epidémiologie / Epidemiology)|
Thésaurus TOXIBASEPRODUIT ILLICITE ; RAVE ; MILIEU FESTIF ; JEUNE ; PROFIL SOCIO-DEMOGRAPHIQUE
Background: The popularity of electronic dance music and rave parties such as dance festivals has increased in recent years. Targeted samples of party-goers suggest high rates of drug use among attendees, but few nationally representative studies have examined these associations.
Methods: We examined sociodemographic correlates of rave attendance and relationships between rave attendance and recent (12-month) use of various drugs in a representative sample of US high school seniors (modal age: 18) from the Monitoring the Future study (2011-2013; Weighted N = 7373).
Results: One out of five students (19.8%) reported ever attending a rave, and 7.7% reported attending at least monthly. Females and highly religious students were less likely to attend raves, and Hispanics, students residing in cities, students with higher income and those who go out for fun multiple times per week were more likely to attend. Rave attendees were more likely than non-attendees to report use of an illicit drug other than marijuana (35.5% vs. 15.6%, p =6 times) of each drug (ps Discussion: Findings from this study can help inform prevention and harm reduction among rave attendees at greatest risk for drug use.
One out of five high school seniors reported ever attending a rave.
Students residing in cities or with higher income were more likely to attend raves.
Rave attendees were more likely to report use and more frequent use of 18 drugs.
Frequent attendance was associated with higher odds of use of each drug.
|Domaine :||Drogues illicites / Illicit drugs|
|Affiliation :||New York University Langone Medical Center, Department of Population Health, New York, NY, USA|